Castle Biosciences' Series B Round

Castle Biosciences raised a round of funding on May 16, 2013. Investors include Mountain Group Capital.

Castle Biosciences is a molecular diagnostics company dedicated to helping patients and their physicians make the best possible decisions about their treatment and follow-up care based on the individu…

Articles about Castle Biosciences' Series B Round: